| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |